Molecular Mechanisms of Bioactive Nutrients Promoting Health through Gut Microbiota
Many food components (such as phytochemicals, carbohydrates, proteins, fats, vitamins, minerals, etc.) have been found to have various biological activities. Based on dietary intake and the availability of nutrients in the intestine, human gut microbiota can produce harmful metabolites that cause hu...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_128625 | ||
005 | 20231130 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20231130s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-8962-6 | ||
020 | |a 9783036589633 | ||
020 | |a 9783036589626 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-8962-6 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
072 | 7 | |a JFCV |2 bicssc | |
100 | 1 | |a Xu, Baojun |4 edt | |
700 | 1 | |a Xu, Baojun |4 oth | |
245 | 1 | 0 | |a Molecular Mechanisms of Bioactive Nutrients Promoting Health through Gut Microbiota |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (180 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Many food components (such as phytochemicals, carbohydrates, proteins, fats, vitamins, minerals, etc.) have been found to have various biological activities. Based on dietary intake and the availability of nutrients in the intestine, human gut microbiota can produce harmful metabolites that cause human diseases or beneficial compounds that prevent host diseases. Abnormal gut microbiota can produce endotoxins, exacerbating chronic inflammation and metabolic disorders. Moreover, gut microbiota is crucial for maintaining metabolism and health, and dysbiosis plays a crucial role in the occurrence and development of various diseases. Therefore, a promising strategy to help manage colon and host health is to regulate the composition of the gut microbiota by eating biologically active food ingredients. Bioactive ingredients obtained from dietary sources can be designed and characterized to meet human nutritional and immune needs and balance gut microbiota. To maximize knowledge on the health effect of gut microbiota on improving human health, a Special Issue titled "Molecular Mechanisms of Bioactive Nutrients Promoting Health through Gut Microbiota" was published in the International Journal of Molecular Science, including nine papers: six research articles and three reviews. Among these six research articles, four are animal studies, one is an in vitro gut microbiota culture study, and one is a randomized clinical study. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
650 | 7 | |a Food & society |2 bicssc | |
653 | |a d-tagatose | ||
653 | |a prebiotic | ||
653 | |a constipation | ||
653 | |a gut microbiota | ||
653 | |a 16S rRNA | ||
653 | |a neurotransmitter | ||
653 | |a chitosan | ||
653 | |a ulcerative colitis | ||
653 | |a tight junction protein | ||
653 | |a intestinal microflora | ||
653 | |a obesity-related inflammation | ||
653 | |a pistachio intake | ||
653 | |a HFD mice | ||
653 | |a adipose tissue | ||
653 | |a in vitro model | ||
653 | |a microbiota | ||
653 | |a prebiotics | ||
653 | |a gas production | ||
653 | |a obesity | ||
653 | |a functionality | ||
653 | |a HT29 | ||
653 | |a RTCA | ||
653 | |a SCFA | ||
653 | |a bifidobacterial-ITS | ||
653 | |a autism spectrum disorder | ||
653 | |a intestinal microbiota | ||
653 | |a food intake | ||
653 | |a Type 2 diabetes | ||
653 | |a leptin | ||
653 | |a diet | ||
653 | |a microbiota metabolism | ||
653 | |a metabolome | ||
653 | |a microbiome therapeutics | ||
653 | |a phytochemicals | ||
653 | |a colon cancer stem cells | ||
653 | |a CRC therapy | ||
653 | |a idiopathic pulmonary fibrosis | ||
653 | |a gut-lung axis | ||
653 | |a n/a | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8077 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/128625 |7 0 |z DOAB: description of the publication |